Literature DB >> 2748749

Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis.

R P Clark1, C E Berris.   

Abstract

Injury to the frontal or other facial nerve branches can result in an asymmetry that can be very distressful to both patient and surgeon. This is especially true following cosmetic procedures such as rhytidectomy. We propose a means to create temporary symmetry while awaiting the possible return of nerve function. Botulinum neurotoxin causes a muscle paralysis lasting for approximately 3 months, and it is well established as the preferred treatment for blepharospasm. A case is presented in which botulinum toxin type A was injected into the opposite functioning frontalis muscle of a patient with unilateral frontal nerve paralysis. The patient experienced satisfactory relief of the asymmetry caused by onesided forehead wrinkling and brow elevation. Botulinum toxin therapy should be considered for both temporary and permanent facial asymmetries due to facial nerve paralysis as well as spasm.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748749

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  12 in total

1.  Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry.

Authors:  Libin Xiao; Lizhen Pan; Bing Li; Yanwen Zhou; Yougui Pan; Xiaolong Zhang; Yong Hu; Dirk Dressler; Lingjing Jin
Journal:  J Neurol       Date:  2018-07-09       Impact factor: 4.849

2.  Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease.

Authors:  J M Olver
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

3.  Noncosmetic periocular therapeutic applications of botulinum toxin.

Authors:  Pelin Kaynak-Hekimhan
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

4.  Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia.

Authors:  John C Bladen; Ilan Feldman; Maribel Favor; Marizol Dizon; Andre Litwin; Raman Malhotra
Journal:  Eye (Lond)       Date:  2018-09-10       Impact factor: 3.775

Review 5.  Periorbital facial rejuvenation; applied anatomy and pre-operative assessment.

Authors:  Mohsen Bahmani Kashkouli; Parya Abdolalizadeh; Navid Abolfathzadeh; Hamed Sianati; Maria Sharepour; Yasaman Hadi
Journal:  J Curr Ophthalmol       Date:  2017-04-25

Review 6.  AbobotulinumtoxinA: A 25-Year History.

Authors:  Gary D Monheit; Andy Pickett
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

7.  Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial.

Authors:  Jae Hyung Ryu; Jae Hang Shim; Jong Hoon Yeom; Woo Jong Shin; Sang Yun Cho; Woo Jae Jeon
Journal:  Korean J Anesthesiol       Date:  2019-06-04

Review 8.  Botulinum Toxin in Aesthetic Medicine: Myths and Realities.

Authors:  Jeffrey S Dover; Gary Monheit; Mark Greener; Andy Pickett
Journal:  Dermatol Surg       Date:  2018-02       Impact factor: 3.398

Review 9.  Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport).

Authors:  Jeffrey S Dover
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

10.  Neurotoxin Impurities: A Review of Threats to Efficacy.

Authors:  Je-Young Park; Owen Sunga; Rungsima Wanitphakdeedecha; Jürgen Frevert
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.